Lexology October 28, 2024
Covington & Burling LLP

Covington advised AbbVie in its definitive agreement to acquire Aliada Therapeutics, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology to address challenging central nervous system (CNS) diseases. Under the terms of the agreement, AbbVie will acquire all outstanding...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year
Walmart To Expand Same-Day Prescription Delivery Nationwide
Podcast: Market Failures, Lessons or Opportunities? 1/30/25
FDA warns GLP-1 compounder over safety rules

Share This Article